Testing effectiveness (Phase 2)Study completedNCT02263040
What this trial is testing
A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIV
Who this might be right for
Influenza
Mount Sinai Hospital, Canada 170